Home Stocks Sanofi India Ltd

Sanofi India Ltd

The live share price of Sanofi India Ltd (SANOFI) as on 29 Apr 4:32am is ₹8,312.45 from NSE/BSE.

SANOFI NSE

₹8,312.45 ▲0.46% (38.3)

As on Apr 29, 2024 10:02 AM IST

How do you feel today about Sanofi India Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

31.61

PB Ratio

18.77

Dividend Yield

2.02%

Sector PB

5.97

Sector PE

53.11

Sector Div Yld

0.54%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹19,055 Cr

Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.

The following charts display the financial performance of the Sanofi India Ltd (SANOFI) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Sanofi India Ltd (SANOFI), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹19,055 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	2,934 Cr	-1.32%
Operating Expense	-164 Cr	-227.11%
Net Income	603 Cr	-2.8%
Net Profit Margin	20.56%	-1.49%
Earning Per Share	261	-2.8%
EBITDA	887 Cr	-2.29%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	404 Cr	-60.18%
Total Assets	1,715 Cr	-17.21%
Total Liabilities	699 Cr	-12.1%
Total Equity	1,015 Cr	-20.4%
Shares Outstanding	2.3 Cr	-0.13%
Price to Book	13.01	-3.36%
Return on Assets	31.86%	+31.76%
Return on Capital	83.46 Cr	+22.95%

Cash Flows

(INR)		Y/Y Change
Net Income	603 Cr	-2.8%
Cash from Operations	230 Cr	-42.11%
Cash from Investing	35 Cr	-94.55%
Cash from Financing	-878 Cr	-44.51%
Net Change in Cash	-612 Cr	+14.8%
Free Cash Flow	196 Cr	-47.81%

Shareholding Pattern

Total Promoter Holding

60.4%

Unpledged

Foreign Institutions

6.11%

Foreign Institutions

Retail & Others

10.41%

Retail & Others

Other Parties

Other Domestic Institutions

11.41%

Insurance Firms

Others

Mutual Funds

11.67%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

40.59

1Y Return

▲52.54%

CIPLA

Cipla Ltd

PE Ratio

30.68

1Y Return

▲55.18%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.91

1Y Return

▲26.82%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

32.06

1Y Return

▲82.23%

Latest News

Sanofi Looks For Accelerated Growth In India, Plans Fast-Tracking Of Product Pipeline

3 weeks ago on Bloomberg Quint

Change since news ▼-INF%

Sanofi Healthcare India recently tied up with companies like Cipla, Dr Reddy’s Laboratories and Emcure to expand the reach of its products in the country.

Sanofi Gets Nod For New Polio Vaccine In India

3 weeks ago on Bloomberg Quint

Change since news ▼-INF%

Sanofi has received approval for IMOVAX-Polio, an alternative injectable vaccine, to replace ShanIP, the inactivated polio vaccine, in India.

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

4 weeks ago on Moneycontrol

Change since news ▼-INF%

Sanofi did not disclose the financial terms of the deal. The agreement, which still needs to be finalized, will resolve most of the lawsuits against the French pharmaceutical company in U.S. state courts, with the exception of Delaware where the majority of the cases are pending.

FAQs on Sanofi India Ltd

How to buy Sanofi India Ltd stocks?

You can easily buy the stocks/shares of Sanofi India Ltd (SANOFI) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Sanofi India Ltd?

The stock price of Sanofi India Ltd as on 29 Apr 2024 is ₹8,312.45

What is the 52-week High and Low of Sanofi India Ltd?

The 52-week high and low of Sanofi India Ltd (SANOFI) is ₹9,380 and ₹5,400.

What is the PE and PB ratio of Sanofi India Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Sanofi India Ltd are 31.61 and 18.77 respectively.

What are the peers or stocks similar to Sanofi India Ltd?

The peers or stocks similar to Sanofi India Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Sanofi India Ltd belong to?

Sanofi India Ltd (SANOFI) belongs to the Pharmaceuticals sector.

What is the Market Cap of Sanofi India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanofi India Ltd (SANOFI) is ₹19,055 Cr as of 29 Apr 2024

Can't decide whether or not to buy Sanofi India Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.